These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10606384)

  • 1. Familial dermatomyositis.
    Plamondon S; Dent PB; Reed AM
    J Rheumatol; 1999 Dec; 26(12):2691-2. PubMed ID: 10606384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic studies in families of children with juvenile dermatomyositis.
    Reed AM; Pachman LM; Hayford J; Ober C
    J Rheumatol; 1998 May; 25(5):1000-2. PubMed ID: 9598907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501.
    Reed AM; Pachman L; Ober C
    Hum Immunol; 1991 Dec; 32(4):235-40. PubMed ID: 1783570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis.
    Reed AM; Stirling JD
    Hum Immunol; 1995 Nov; 44(3):131-5. PubMed ID: 8666549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
    Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis.
    Tomono N; Mori M; Nakajima S; Miyamae T; Ito S; Mitsuda T; Yokota S
    J Rheumatol; 2004 Sep; 31(9):1847-50. PubMed ID: 15338511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile dermatomyositis: a retrospective review of a 30-year experience.
    Peloro TM; Miller OF; Hahn TF; Newman ED
    J Am Acad Dermatol; 2001 Jul; 45(1):28-34. PubMed ID: 11423831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year experience of juvenile dermatomyositis: a retrospective study.
    Chiu SK; Yang YH; Wang LC; Chiang BL
    J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenetic studies of juvenile dermatomyositis. HLA antigens in patients and their families.
    Friedman JM; Pachman LM; Maryjowski ML; Jonasson O; Battles ND; Crowe WE; Fink CW; Hanson V; Levinson JE; Spencer CH; Sullivan DB
    Tissue Antigens; 1983 Jan; 21(1):45-9. PubMed ID: 6601315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial neoplasms and childhood dermatomyositis].
    Frati AC; Lugones RF; Figueroa JA; Criollos O; Martínez-Cairo S
    Prensa Med Mex; 1978; 43(5-6):166-71. PubMed ID: 748911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens.
    Pachman LM; Friedman JM; Maryjowski-Sweeney ML; Jonnason O; Radvany RM; Sharp GC; Cobb MA; Battles ND; Crowe WE; Fink CW
    Arthritis Rheum; 1985 Feb; 28(2):151-7. PubMed ID: 3871616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrodermic juvenile dermatomyositis.
    Chander R; Gupta T; Rani S; Nagia A
    Pediatr Dermatol; 2009; 26(2):234-5. PubMed ID: 19419488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile dermatomyositis.
    Pachman LM
    Pediatr Clin North Am; 1986 Oct; 33(5):1097-117. PubMed ID: 3532004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial CREST syndrome.
    McColl GJ; Buchanan RR
    J Rheumatol; 1994 Apr; 21(4):754-6. PubMed ID: 8035406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile amyopathic dermatomyositis.
    Henning JS; Witkiewicz A; Schaffer JV; Orlow SJ
    Dermatol Online J; 2005 Dec; 11(4):11. PubMed ID: 16403383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile dermatomyositis: 4 case studies].
    Marcil T; Khoudri I; Meziane M; Beqqal K; Khatibi I; Hassam B; Afifi Y; Benzekri L
    Arch Pediatr; 2008 Sep; 15(9):1443-5. PubMed ID: 18676126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course of treated juvenile dermatomyositis.
    Spencer CH; Hanson V; Singsen BH; Bernstein BH; Kornreich HK; King KK
    J Pediatr; 1984 Sep; 105(3):399-408. PubMed ID: 6470862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis?
    Reed AM; McNallan K; Wettstein P; Vehe R; Ober C
    J Immunol; 2004 Apr; 172(8):5041-6. PubMed ID: 15067086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.
    Pachman LM; Liotta-Davis MR; Hong DK; Kinsella TR; Mendez EP; Kinder JM; Chen EH
    Arthritis Rheum; 2000 Oct; 43(10):2368-77. PubMed ID: 11037898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
    Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
    Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.